Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Recordati Industria Chimica E Farmaceutica SpA Raises FY 2013 Revenues Guidance


Thursday, 9 May 2013 06:44am EDT 

Recordati Industria Chimica E Farmaceutica SpA announced that it has revised and raised the Company's revenues, operating income and net income guidance for fiscal year 2013. The Company expects to report for fiscal year 2013 revenues of approximately EUR 930 million, operating income of approximately EUR 190 million and net income of approximately EUR 132 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report for fiscal year 2013 revenues of EUR 920.84 million, EBIT of EUR 189.61 million, net income of EUR 135.53 million. 

Related Company News

Company Quote